- Home
- OPTX vs VRCA Comparison
OPTX vs VRCA Comparison
Compare OPTX & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- VRCA
- Stock Information
- Founded
- OPTX 1981
- VRCA 2013
- Country
- OPTX United States
- VRCA United States
- Employees
- OPTX N/A
- VRCA N/A
- Industry
- OPTX Blank Checks
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- OPTX Finance
- VRCA Health Care
- Exchange
- OPTX Nasdaq
- VRCA Nasdaq
- Market Cap
- OPTX 51.9M
- VRCA 54.0M
- IPO Year
- OPTX N/A
- VRCA 2018
- Fundamental
- Price
- OPTX $1.35
- VRCA $0.69
- Analyst Decision
- OPTX
- VRCA Hold
- Analyst Count
- OPTX 0
- VRCA 5
- Target Price
- OPTX N/A
- VRCA $6.00
- AVG Volume (30 Days)
- OPTX 73.5K
- VRCA 632.2K
- Earning Date
- OPTX 08-13-2025
- VRCA 08-13-2025
- Dividend Yield
- OPTX N/A
- VRCA N/A
- EPS Growth
- OPTX N/A
- VRCA N/A
- EPS
- OPTX 0.00
- VRCA N/A
- Revenue
- OPTX $29,392,186.00
- VRCA $7,179,000.00
- Revenue This Year
- OPTX N/A
- VRCA $171.87
- Revenue Next Year
- OPTX N/A
- VRCA $71.38
- P/E Ratio
- OPTX $822.94
- VRCA N/A
- Revenue Growth
- OPTX 4.00
- VRCA N/A
- 52 Week Low
- OPTX $0.85
- VRCA $0.38
- 52 Week High
- OPTX $5.10
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- OPTX 48.96
- VRCA 58.87
- Support Level
- OPTX $1.31
- VRCA $0.52
- Resistance Level
- OPTX $1.47
- VRCA $0.67
- Average True Range (ATR)
- OPTX 0.10
- VRCA 0.06
- MACD
- OPTX 0.01
- VRCA 0.00
- Stochastic Oscillator
- OPTX 66.33
- VRCA 71.58
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.